AAL vs DMAC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

AAL

37.9
AI Score
VS
DMAC Wins

DMAC

43.8
AI Score

Investment Advisor Scores

AAL

38score
Recommendation
SELL

DMAC

44score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric AAL DMAC Winner
Net Income 111.00M -20.18M AAL
Operating Income 1.47B -20.98M AAL
ROE -3.0% -52.6% AAL
ROA 0.2% -44.8% AAL
Total Assets 61.77B 45.00M AAL
Cash 954.00M 5.13M AAL
Current Ratio 0.50 6.72 DMAC

Relative Price Performance (Last 90 Days)

AAL 1M: +12.9% · 3M: -10.2% DMAC 1M: +21.8% · 3M: +39.7%

Current Technical Phase

AAL

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 52.2 · Price: $13.31

DMAC

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (13.9% over 20 days), RSI 54

RSI (14): 54.0 · Price: $9.33

Fundamentals Snapshot

Metric AAL DMAC
Market Cap — —
Forward P/E 14.1 -12.5
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.2% 0.0%
Gross Margin 0.2% —
Operating Margin 0.0% 0.0%
EPS -0.73 -0.72
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, DMAC is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.